Detalhe da pesquisa
1.
Current and emerging therapies for eosinophilic esophagitis.
Allergy Asthma Proc
; 43(3): 178-186, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35524356
2.
AR101 Oral Immunotherapy for Peanut Allergy.
N Engl J Med
; 379(21): 1991-2001, 2018 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30449234
3.
Safety of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in children: A randomized clinical trial.
Allergy Asthma Proc
; 39(2): 110-116, 2018 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29490769
4.
Real-world use of omalizumab in patients with chronic idiopathic/spontaneous urticaria in the United States.
Allergy Asthma Proc
; 39(3): 191-200, 2018 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29458456
5.
Medical therapy versus dietary avoidance in eosinophilic esophagitis: Which approach is better?
Allergy Asthma Proc
; 38(3): 170-176, 2017 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28441986
6.
Intranasal corticosteroids: the role of patient preference and satisfaction.
Allergy Asthma Proc
; 35(1): 24-33, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24433594
7.
Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population.
J Allergy Clin Immunol Pract
; 12(5): 1215-1224.e3, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38360213
8.
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study.
J Allergy Clin Immunol Pract
; 9(5): 1879-1889.e13, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33359589